Frontlight ResearchEarly access
Trial site
UCL Mont-Godinne
- 6running trials
- 10closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Diffuse large B-cell lymphoma2 trials
- Follicular lymphoma2 trials
- Colorectal cancer1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Head and neck cancer1 trial
- Idiopathic pulmonary fibrosis1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Pancreatic cancer1 trial
- and 2 more
- Phase
- Phase 311 trials
- Phase 22 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed10 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Lead sponsor
- Incyte Corporation2 trials
- AstraZeneca1 trial
- AZ Sint-Jan AV1 trial
- Boehringer Ingelheim1 trial
- Bristol-Myers Squibb1 trial
- and 10 more
Running trials
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026